The global uterine fibroid treatment devices market is technologically diverse segment with presence of large number of players. The market offers significant growth opportunities in the next five years to major as well as new players that are aspiring to enter into this medical device segment.

A number of factors such as growing population base for uterine fibroid patients, technological advancements in the field of uterine/endometrial ablation & laparoscopic devices, sprouting number of hospitals & surgical centers, and growing awareness about minimally invasive and non-invasive procedures to treat uterine fibroids are stimulating the growth of global uterine fibroid treatment devices market. However, high cost-containment measures taken by various governments and ongoing healthcare reforms in the U.S. are some of the key factors restraining this market.

The emerging markets including China, India, Brazil, and Mexico have become attractive destinations for companies engaged in the development, manufacturing, and distribution of uterine fibroid treatment devices. A number of factors such as recent clinical success of endometrial ablation & laparoscopic surgical procedures during clinical evaluation for their application in uterine fibroid treatment, ongoing modernization & expansion of healthcare infrastructure across developing countries, and growing market penetration of product manufacturers & demand across rural regions from emerging markets are offering high growth opportunities for the players’ active in the global uterine fibroid treatment devices market.